RediNews
ETFs Holding ABBV »    ABBV Historical Stock Prices »
ABBV News Video: Mon, Mar 20, 2017, 10:47 AM — PEY, PERM: Big ETF Inflows


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. Co. also has new medicines across such medical specialties as immunology, virology, oncology and neurology, with additional targeted investment in cystic fibrosis and women's health. Self directed investors in AbbVie Inc will be interested in keeping up with all AbbVie Inc news they can find, both ABBV news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ABBV. At RediNews, we simplify this task by presenting both ABBV news releases originating from AbbVie Inc itself, and ABBV news from a variety of media outlets. Visitors can browse this news online and through our ABBV RSS news feed.

ABBV News

ABBV News — Articles, Videos, & Press Releases

Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Friday, March 24, 2017, 9:27 AM — Zacks
Notable ETF Inflow Detected - VV, ORCL, ABBV, USB
Wednesday, March 22, 2017, 12:06 PM — ETF Channel
First Week of ABBV November 17th Options Trading
Tuesday, March 21, 2017, 10:38 AM — Stock Options Channel
5 Dividend Aristocrats Where Analysts See Capital Gains
Monday, March 20, 2017, 9:34 AM — ETF Channel
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
Thursday, March 16, 2017, 8:49 AM — Zacks
Infinity (INFI) Reports Narrower-than-Expected Loss in Q4
Wednesday, March 15, 2017, 9:36 AM — Zacks
Noteworthy ETF Inflows: XLV, AMGN, MDT, ABBV
Monday, March 13, 2017, 10:49 AM — ETF Channel
ABBV Named Top 25 SAFE Dividend Stock Increasing Payments For Decades
Monday, March 13, 2017, 7:38 AM — ETF Channel
AbbVie Now #43 Largest Company, Surpassing McDonald's
Friday, March 10, 2017, 4:36 PM — Market News Video
The New #167 Most Shorted S&P 500 Component: AbbVie
Friday, March 10, 2017, 1:37 PM — Market News Video
Noteworthy Tuesday Option Activity: HUM, ABBV, UAA
Tuesday, March 7, 2017, 3:30 PM — Stock Options Channel
Novartis (NVS) Reports Positive Data on Biosimilar Humira
Tuesday, March 7, 2017, 3:21 PM — Zacks
Inovio (INO): What's in the Cards this Earnings Season?
Monday, March 6, 2017, 8:28 AM — Zacks
BioDelivery (BDSI): What's in Store this Earnings Season?
Monday, March 6, 2017, 8:21 AM — Zacks
XLV, AMGN, MDT, ABBV: ETF Inflow Alert
Friday, March 3, 2017, 11:58 AM — ETF Channel
Pricing to Remain Pharma Headline Risk in 2017
Wednesday, March 1, 2017, 5:43 PM — Zacks
Noteworthy Thursday Option Activity: GRA, BOX, ABBV
Thursday, February 23, 2017, 3:37 PM — Stock Options Channel
Vanguard Large-Cap ETF Experiences Big Outflow
Wednesday, February 22, 2017, 10:52 AM — ETF Channel
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Friday, February 17, 2017, 7:13 AM — Zacks
5 Dividend Aristocrats Where Analysts See Capital Gains
Thursday, February 16, 2017, 8:26 AM — ETF Channel
Gilead (GILD) Announces Data on Combination Therapy for HIV
Tuesday, February 14, 2017, 3:18 PM — Zacks
Vanguard Growth ETF Experiences Big Inflow
Tuesday, February 14, 2017, 10:48 AM — ETF Channel
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Monday, February 13, 2017, 8:19 AM — Zacks
AbbVie Becomes #173 Most Shorted S&P 500 Component, Replacing Newell Brands
Friday, February 10, 2017, 2:01 PM — Market News Video
Why AbbVie is a Top 25 Dividend Giant (ABBV)
Thursday, February 9, 2017, 8:07 AM — ETF Channel
Gilead (GILD) Beats Q4 Earnings & Sales, View Disappoints
Wednesday, February 8, 2017, 9:16 AM — Zacks
The Zacks Analyst Blog Highlights: Apple, Visa and AbbVie
Wednesday, February 8, 2017, 8:30 AM — Zacks
VUG, AMGN, MMM, ABBV: Large Inflows Detected at ETF
Monday, February 6, 2017, 10:55 AM — ETF Channel
Roche (RHHBY) Beats on Earnings in 2016, Misses on Sales
Thursday, February 2, 2017, 9:54 AM — Zacks
AbbVie (ABBV) HCV Regimen Gets Priority Review in Canada
Thursday, February 2, 2017, 5:51 AM — Zacks
Analysts Forecast 15% Upside For The Holdings of XLV
Monday, January 30, 2017, 9:13 AM — ETF Channel
Key Takeaways from AbbVie's Q4 Call: Humira and the Pipeline
Monday, January 30, 2017, 7:21 AM — Zacks
Pfizer (PFE) Gets Positive CHMP Opinion for Arthritis Drug
Monday, January 30, 2017, 6:37 AM — Zacks
Amgen Wins Favorable CHMP Opinion for Humira Biosimilar
Monday, January 30, 2017, 6:34 AM — Zacks
AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
Friday, January 27, 2017, 1:42 PM — Zacks
VOO, AMGN, MMM, ABBV: Large Outflows Detected at ETF
Friday, January 27, 2017, 10:48 AM — ETF Channel
AbbVie (ABBV) Reports In-Line Q4 Earnings, Revenues Miss
Friday, January 27, 2017, 8:27 AM — Zacks
Friday's Best Earnings Charts
Thursday, January 26, 2017, 2:57 PM — Zacks
Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft
Thursday, January 26, 2017, 8:32 AM — Zacks
AbbVie's HCV Regimen Okayed for Accelerated Assessment
Wednesday, January 25, 2017, 9:28 AM — Zacks
Noteworthy Tuesday Option Activity: ABBV, MU, MGM
Tuesday, January 24, 2017, 3:29 PM — Stock Options Channel
Sunesis Offers Updates on SNS-062 and Qinprezo Programs
Tuesday, January 24, 2017, 3:06 PM — Zacks
Can AbbVie (ABBV) Spring a Surprise This Earnings Season?
Tuesday, January 24, 2017, 3:04 PM — Zacks
Gilead (GILD) HCV Therapy Application Validated in Europe
Monday, January 23, 2017, 4:26 PM — Zacks
Can Q4 Earnings Revitalize Healthcare ETFs?
Monday, January 23, 2017, 10:01 AM — Zacks
What's in Store for Abbott Labs (ABT) This Earnings Season?
Friday, January 20, 2017, 4:53 PM — Zacks
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Friday, January 20, 2017, 1:52 PM — Zacks
4 Drug Stocks Poised to Surprise this Earnings Season
Friday, January 20, 2017, 1:41 PM — Zacks
Abbvie (ABBV) Imbruvica Approved in Lymphoma Indication
Friday, January 20, 2017, 7:14 AM — Zacks
4 Best Marijuana Stocks to Play the Green Rush
Thursday, January 19, 2017, 2:47 PM — Zacks
Noteworthy ETF Inflows: VUG, AMGN, MMM, ABBV
Thursday, January 19, 2017, 10:51 AM — ETF Channel
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?
Thursday, January 19, 2017, 9:17 AM — Zacks
Allergan's Uterine Fibroids Candidate Positive in Phase III
Wednesday, January 18, 2017, 3:22 PM — Zacks
Coherus Offers Positive Phase III Data on Humira Biosimilar
Friday, January 13, 2017, 8:55 AM — Zacks
AT&T Becomes #132 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, January 12, 2017, 2:30 PM — Market News Video
Trump Attacks Biotech & Pharma: ETFs Bleed
Thursday, January 12, 2017, 9:08 AM — Zacks
Notable Wednesday Option Activity: ABBV, TSLA, CRM
Wednesday, January 11, 2017, 3:32 PM — Stock Options Channel
XLV, UNH, ABBV, MDT: Large Inflows Detected at ETF
Tuesday, January 10, 2017, 10:50 AM — ETF Channel
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Monday, January 9, 2017, 10:39 AM — Dividend Channel
Pfizer's Humira Biosimilar Meets Primary Endpoint in Study
Friday, January 6, 2017, 7:21 AM — Zacks
Notable Wednesday Option Activity: CHTR, GPS, ABBV
Wednesday, January 4, 2017, 2:27 PM — Stock Options Channel
Agree To Buy AbbVie At $30, Earn 4.1% Using Options
Tuesday, January 3, 2017, 11:51 AM — Stock Options Channel
How The Parts Add Up: IVW Headed For $135
Thursday, December 29, 2016, 10:21 AM — ETF Channel
The New #132 Most Shorted S&P 500 Component: AbbVie
Wednesday, December 28, 2016, 1:49 PM — Market News Video
Noteworthy ETF Inflows: XLV, UNH, ABBV, AGN
Friday, December 23, 2016, 10:53 AM — ETF Channel
Roche (RHHBY) Hemophilia A Drug Positive in Phase III
Friday, December 23, 2016, 7:25 AM — Zacks
AbbVie Breaks Below 200-Day Moving Average - Notable for ABBV
Wednesday, December 21, 2016, 4:50 PM — Dividend Channel
AbbVie (ABBV) Submits NDA for Next-Gen HCV Combo in US
Tuesday, December 20, 2016, 8:40 AM — Zacks
J&J Files sBLA for Plaque Psoriasis in Adolescent Patients
Monday, December 19, 2016, 9:30 AM — Zacks
5 Dividend Aristocrats Where Analysts See Capital Gains
Friday, December 16, 2016, 9:07 AM — ETF Channel
Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Friday, December 16, 2016, 7:17 AM — Zacks
Gilead to Pay Merck $2.5B in HCV Patent Dispute, Stock Falls
Friday, December 16, 2016, 6:57 AM — Zacks
ABBV Named A Top Socially Responsible Dividend Stock
Thursday, December 15, 2016, 7:22 AM — ETF Channel
XLV, AMGN, ABBV, GILD: ETF Outflow Alert
Wednesday, December 14, 2016, 10:47 AM — ETF Channel
Roche/AbbVie's Leukemia Drug Venclyxto Gains EU Approval
Monday, December 12, 2016, 8:54 AM — Zacks
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Tuesday, December 6, 2016, 9:37 AM — Zacks
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Monday, December 5, 2016, 8:36 AM — Zacks
Notable ETF Inflow Detected - IUSG, GOOG, ABBV, BMY
Thursday, December 1, 2016, 10:48 AM — ETF Channel
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Thursday, December 1, 2016, 9:21 AM — Zacks
Momenta/Shire's Humira Biosimilar Meets Study Objective
Wednesday, November 30, 2016, 8:58 AM — Zacks
We Did The Math MGK Can Go To $98
Monday, November 28, 2016, 9:04 AM — ETF Channel
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Wednesday, November 23, 2016, 7:24 AM — Zacks
J&J (JNJ) Files for Psoriasis Candidate Guselkumab in U.S.
Friday, November 18, 2016, 3:42 PM — Zacks
Notable ETF Inflow Detected - XLV, AMGN, ABBV, GILD
Friday, November 18, 2016, 10:51 AM — ETF Channel
Sanofi/Regeneron Present Sarilumab Data at ACR Meeting
Friday, November 18, 2016, 5:18 AM — Zacks
Glaxo (GSK) Presents Phase III Data on Sirukumab & Benlysta
Thursday, November 17, 2016, 9:51 PM — Zacks
J&J (JNJ) Stelara Gets Approval in EU for Label Expansion
Thursday, November 17, 2016, 9:15 AM — Zacks
Amgen Files for Avastin Biosimilar; Repatha Data Positive
Wednesday, November 16, 2016, 7:17 AM — Zacks
Incyte, Eli Lilly Offer Positive Phase III Data on Baricitinib
Tuesday, November 15, 2016, 4:33 PM — Zacks
AbbVie's (ABBV) Humira Wins CHMP Backing for Expanded Use
Monday, November 14, 2016, 4:19 PM — Zacks
Merck's Triple Combination HCV Therapy Positive in Phase III
Monday, November 14, 2016, 8:26 AM — Zacks
Noteworthy Wednesday Option Activity: ABBV, JNJ, PRU
Wednesday, November 9, 2016, 1:35 PM — Stock Options Channel
IYH, UNH, AMGN, ABBV: ETF Outflow Alert
Tuesday, November 8, 2016, 10:53 AM — ETF Channel
Pharma Industry Outlook - November 2016
Thursday, November 3, 2016, 3:08 PM — Zacks
Health Care Select Sector SPDR Fund Experiences Big Outflow
Monday, October 31, 2016, 10:47 AM — ETF Channel
ABBV Crosses Above 4% Yield Territory
Friday, October 28, 2016, 3:18 PM — Dividend Channel
AbbVie is Oversold
Friday, October 28, 2016, 11:40 AM — Dividend Channel
Notable Friday Option Activity: CBI, ABBV, STRP
Friday, October 28, 2016, 11:26 AM — Stock Options Channel
AbbVie (ABBV) Q3 Earnings in Line, Revenues Lag Estimates
Friday, October 28, 2016, 9:23 AM — Zacks
Timeout from Q3 Earnings: GDP +2.9%
Friday, October 28, 2016, 8:17 AM — Zacks
AbbVie (ABBV) Reports In-Line Q3 Earnings, Revenues Miss
Friday, October 28, 2016, 7:24 AM — Zacks
Amgen (AMGN) Q3 Earnings & Sales Top; Enbrel Hurts Stock
Friday, October 28, 2016, 7:03 AM — Zacks
Analysts Anticipate 19% Upside For The Holdings of XLV
Thursday, October 27, 2016, 9:16 AM — ETF Channel
Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN
Thursday, October 27, 2016, 6:04 AM — Zacks
Can AbbVie (ABBV) Sustain Earnings Beat Trend in Q3?
Monday, October 24, 2016, 2:27 PM — Zacks
Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?
Monday, October 24, 2016, 8:28 AM — Zacks
iShares U.S. Healthcare ETF Experiences Big Outflow
Friday, October 21, 2016, 10:46 AM — ETF Channel
Will Amgen (AMGN) Sustain its Earnings Beat Trend in Q3?
Friday, October 21, 2016, 8:47 AM — Zacks
Bristol-Myers Squibb (BMY) Q3 Earnings: What's in Store?
Friday, October 21, 2016, 7:26 AM — Zacks
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q3?
Thursday, October 20, 2016, 8:21 AM — Zacks
See Which Of The Latest 13F Filers Holds AbbVie
Wednesday, October 19, 2016, 10:54 AM — Dividend Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Monday, October 17, 2016, 8:49 AM — ETF Channel
Roche's Lucentis Prefilled Syringe Approved in the U.S.
Monday, October 17, 2016, 7:49 AM — Zacks
Celgene to Present Phase Ib Data on Crohn's Disease Drug
Monday, October 17, 2016, 7:24 AM — Zacks
AbbVie (ABBV) Shares Cross Below 200 DMA
Friday, October 14, 2016, 4:20 PM — Dividend Channel
Health Care Select Sector SPDR Fund Experiences Big Inflow
Thursday, October 13, 2016, 10:55 AM — ETF Channel
The New #111 Most Shorted S&P 500 Component: Xilinx
Thursday, October 13, 2016, 7:05 AM — Market News Video
Ex-Dividend Reminder: Foot Locker, Patterson Companies and AbbVie
Monday, October 10, 2016, 10:05 AM — Dividend Channel
Repros' Secondary Hypogonadism Drug under Review in EU
Monday, October 10, 2016, 7:20 AM — Zacks
Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B
Friday, October 7, 2016, 8:36 AM — Zacks
How To YieldBoost AbbVie From 3.6% To 7.3% Using Options
Wednesday, October 5, 2016, 11:39 AM — Stock Options Channel
XLV, AMGN, MDT, ABBV: ETF Outflow Alert
Wednesday, October 5, 2016, 10:53 AM — ETF Channel
J&J's Psoriasis Drug Shows Superior Efficacy Over Humira
Monday, October 3, 2016, 1:39 PM — Zacks
AbbVie: HCV Regimen Obtains Breakthrough Therapy Status
Monday, October 3, 2016, 8:25 AM — Zacks
Vertex Orkambi's Label Expanded in U.S., Outlook Revised
Friday, September 30, 2016, 8:40 AM — Zacks
Bristol-Myers, Nektar Tie-Up for Opdivo/NKTR-214 Combo
Wednesday, September 28, 2016, 3:51 PM — Zacks
The New #171 Most Shorted S&P 500 Component: Anthem
Tuesday, September 27, 2016, 3:19 PM — Market News Video
Notable ETF Outflow Detected - UPRO, ABBV, SBUX, PCLN
Tuesday, September 27, 2016, 10:54 AM — ETF Channel
AbbVie (ABBV) Files sNDA for Blood Cancer Drug Imbruvica
Tuesday, September 27, 2016, 8:14 AM — Zacks
Biosimilars in Limelight on FDA Approval of Amgen Drug
Tuesday, September 27, 2016, 6:23 AM — Zacks
As Humira Alternative Gets FDA Approval, Is Abbvie in Trouble?
Monday, September 26, 2016, 12:20 PM — Zacks
Analysts Predict 10% Gains Ahead For The Holdings of XLG
Monday, September 26, 2016, 9:53 AM — ETF Channel
Stock Market News for September 26, 2016
Monday, September 26, 2016, 8:10 AM — Zacks
AbbVie (ABBV) HCV Combination Drug Positive in Phase IIIb
Monday, September 26, 2016, 6:46 AM — Zacks
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
Monday, September 26, 2016, 4:49 AM — Zacks
Noteworthy ETF Outflows: XLV, MDT, GILD, ABBV
Monday, September 19, 2016, 12:02 PM — ETF Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Thursday, September 15, 2016, 8:20 AM — ETF Channel
Short Interest Decreases By 18.6% For ABBV
Tuesday, September 13, 2016, 12:53 PM — Market News Video
Why AbbVie is a Top 25 SAFE Dividend Stock
Monday, September 12, 2016, 9:11 AM — ETF Channel
3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016
Monday, September 12, 2016, 7:23 AM — Zacks
Notable ETF Outflow Detected - XLV, ABBV, TMO, ABT
Friday, September 9, 2016, 11:04 AM — ETF Channel
IVV, AMZN, FB, ABBV: ETF Outflow Alert
Thursday, September 1, 2016, 10:50 AM — ETF Channel
Clorox Becomes #62 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, August 25, 2016, 3:13 PM — Market News Video
Surprising Analyst 12-Month Target For XLG
Thursday, August 25, 2016, 8:03 AM — ETF Channel
Tuesday Sector Laggards: Utilities, Healthcare
Tuesday, August 23, 2016, 2:32 PM — Market News Video
XLV, MDT, ABBV, AGN: ETF Inflow Alert
Monday, August 22, 2016, 11:02 AM — ETF Channel
How Value Investors Can Buy Growth
Wednesday, August 17, 2016, 4:03 PM — Zacks
J&J's (JNJ) Depression Treatment Esketamine Gets BTD
Wednesday, August 17, 2016, 4:50 AM — Zacks
Notable Tuesday Option Activity: URBN, C, ABBV
Tuesday, August 16, 2016, 2:38 PM — Stock Options Channel
AbbVie a Top 25 Dividend Giant With 3.41% Yield (ABBV)
Friday, August 12, 2016, 7:46 AM — ETF Channel
Foot Locker Becomes #74 Most Shorted S&P 500 Component, Replacing AbbVie
Wednesday, August 10, 2016, 2:35 PM — Market News Video
Notable ETF Outflow Detected - DGRO, ABBV, AMGN, UPS
Monday, August 8, 2016, 10:59 AM — ETF Channel
4 Biotech Stocks Poised to Surprise This Earnings Season
Wednesday, August 3, 2016, 2:18 PM — Zacks
Company News for August 01, 2016
Monday, August 1, 2016, 8:10 AM — Zacks
What Awaits MNK & Other Drug Stocks this Earnings Season?
Monday, August 1, 2016, 8:00 AM — Zacks
DLN, KMI, MO, ABBV: ETF Inflow Alert
Thursday, July 28, 2016, 11:19 AM — ETF Channel
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Thursday, July 28, 2016, 4:47 AM — Zacks
AbbVie Moves Up In Market Cap Rank, Passing McDonald's
Wednesday, July 27, 2016, 4:38 PM — Market News Video
AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?
Tuesday, July 26, 2016, 8:11 AM — Zacks
Roche (RHHBY) Misses on Q2 Revenues, New Launches in Focus
Monday, July 25, 2016, 4:32 PM — Zacks
See Which Of The Latest 13F Filers Holds AbbVie
Monday, July 25, 2016, 9:36 AM — Dividend Channel
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
Thursday, July 21, 2016, 12:00 PM — Zacks
iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow
Wednesday, July 20, 2016, 10:49 AM — ETF Channel
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan
Thursday, July 14, 2016, 8:16 AM — Zacks
5 Dividend Aristocrats Where Analysts See Capital Gains
Thursday, July 14, 2016, 7:57 AM — ETF Channel
Five S&P 500 Stocks With Rising Short Activity
Wednesday, July 13, 2016, 2:46 PM — Market News Video
Larry Robbins Vs. The Shorts: Five Surprising Holdings
Wednesday, July 13, 2016, 1:07 PM — Dividend Channel
Notable Tuesday Option Activity: UNP, ULTA, ABBV
Tuesday, July 12, 2016, 3:39 PM — Stock Options Channel
ITOT, MMM, ABBV, SBUX: ETF Inflow Alert
Tuesday, July 12, 2016, 10:58 AM — ETF Channel
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S.
Tuesday, July 12, 2016, 8:19 AM — Zacks
Analysts Predict 10% Gains Ahead For OEF
Monday, July 11, 2016, 8:07 AM — ETF Channel
Amgen Humira Biosimilar Briefing Documents Look Good
Monday, July 11, 2016, 6:04 AM — Zacks
Commit To Purchase AbbVie At $32.50, Earn 2.8% Using Options
Wednesday, July 6, 2016, 11:48 AM — Stock Options Channel
UCB's Vimpat Approved in Japan for Partial Onset Seizures
Wednesday, July 6, 2016, 8:47 AM — Zacks
Amgen's Kyprolis Gains Approval in EU for Label Expansion
Wednesday, July 6, 2016, 8:37 AM — Zacks
Notable ETF Inflow Detected - DHS, MO, KMI, ABBV
Friday, July 1, 2016, 10:52 AM — ETF Channel
ABBV is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

BDSI News
CYH News
USPH News
THRX News
IPCM News
HALO News
NKTR News
SPPI News
EXEL News
HSP News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ABBV News | www.RediNews.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.